Imvanex

Modified Vaccinia Ankara (MVA), the active ingredient in Imvanex, is a live attenuated vaccine presented as a 0.5 mL lyophilized powder for reconstitution for subcutaneous use. It prevents smallpox and monkeypox in individuals at risk.

GNH USA supplies Imvanex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Imvanex is a live attenuated viral vaccine used for prophylaxis against orthopoxvirus infections.

- Smallpox: provides immunity to prevent infection with variola virus. - Monkeypox: induces protection against monkeypox virus exposure. - Pre‑exposure prophylaxis for high‑risk groups: offers protection before potential orthopoxvirus exposure.

Common Side Effects: - Injection site pain: mild to moderate discomfort at the injection site. - Redness or swelling: localized erythema or edema. - Fever: transient low‑grade temperature rise. - Headache: mild to moderate headache. - Fatigue: temporary tiredness. - Myalgia: muscle aches.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Myocarditis: inflammation of the heart muscle, rare but serious. - Encephalitis: inflammation of the brain, extremely rare. - Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Guillain‑Barré syndrome: rare peripheral neuropathy. - Thrombocytopenia: low platelet count, potentially leading to bleeding.

Before administering Imvanex, consider the following precautions.

- Immunocompromised patients: avoid use in individuals with severe immune deficiency. - Skin conditions: contraindicated in persons with eczema, atopic dermatitis, or other exfoliative skin diseases. - Acute illness: postpone vaccination if the patient has a fever or acute infection. - Pregnancy: safety not established; use only if potential benefits outweigh risks. - Breastfeeding: limited data; assess risk‑benefit before use. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Imvanex may interact with other medical interventions as follows.

Major Interactions (Avoid): - Concurrent live vaccines: avoid administering other live vaccines within four weeks. - High‑dose corticosteroids: may reduce vaccine efficacy and increase risk of infection. - Chemotherapy or radiotherapy: immunosuppression can diminish immune response.

Moderate Interactions (Monitor Closely): - Immunomodulatory agents (e.g., biologics): monitor for adequate seroconversion. - Antiviral medications: may theoretically affect vaccine virus, though clinical relevance is low. - Diagnostic tests using live virus: schedule appropriately to avoid interference.